These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32941363)

  • 21. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
    Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Fever Advisory Cards (FACs) as an Initiative to Improve Febrile Neutropenia Management in a Regional Cancer Center Emergency Department.
    Kapil P; MacMillan M; Carvalho M; Lymburner P; Fung R; Almeida B; Van Dorn L; Enright K
    J Oncol Pract; 2016 Sep; 12(9):e858-63. PubMed ID: 27486160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.
    Pettit N; Boadu D; Bischof JJ
    Am J Emerg Med; 2021 Dec; 50():5-9. PubMed ID: 34265732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-to-antibiotic administration as a quality of care measure in children with febrile neutropenia: a survey of pediatric oncology centers.
    McCavit TL; Winick N
    Pediatr Blood Cancer; 2012 Feb; 58(2):303-5. PubMed ID: 21509930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving Antibiotic Timing in Febrile Neutropenia for Pediatric Oncology Patients with a Central Line.
    Roseland J
    J Pediatr Oncol Nurs; 2021; 38(3):185-189. PubMed ID: 33616449
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of febrile neutropenia in pediatric oncology across Queensland, Australia: a retrospective review on variations between locations.
    Cox A; Bradford N
    J Pediatr Oncol Nurs; 2014; 31(1):28-33. PubMed ID: 24378817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timing of initial antibiotic treatment for febrile neutropenia in the emergency department: the need for evidence-based guidelines.
    Kyriacou DN; Jovanovic B; Frankfurt O
    J Natl Compr Canc Netw; 2014 Nov; 12(11):1569-73. PubMed ID: 25361804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence.
    Karandikar MV; Milliren CE; Zaboulian R; Peiris P; Sharma T; Place AE; Sandora TJ
    J Pediatric Infect Dis Soc; 2020 Sep; 9(4):428-436. PubMed ID: 31603472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
    Kamonrattana R; Sathitsamitphong L; Choeyprasert W; Charoenkwan P; Natesirinilkul R; Fanhchaksai K
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2733-2737. PubMed ID: 31554370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
    Borget I; Antoun S; Chachaty E; Gachot B; Alibay A; Di Palma M; Merad M
    Bull Cancer; 2014 Oct; 101(10):925-31. PubMed ID: 25373692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia.
    Ko BS; Ahn S; Lee YS; Kim WY; Lim KS; Lee JL
    Support Care Cancer; 2015 Sep; 23(9):2799-804. PubMed ID: 25663578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
    Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
    Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients.
    Alali M; Prather C; Danziger-Isakov LA; Kussin ML; Khalifeh M; Al Othman N; Bartlett AH
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e702-e709. PubMed ID: 37494607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiology and clinical course of febrile neutropenia in children with cancer.
    Hakim H; Flynn PM; Knapp KM; Srivastava DK; Gaur AH
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):623-9. PubMed ID: 19644403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA.
    Koenig C; Morgan J; Ammann RA; Sung L; Phillips B
    Syst Rev; 2019 Apr; 8(1):82. PubMed ID: 30944024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting fever in neutropenia with safety-relevant events in children undergoing chemotherapy for cancer: The prospective multicenter SPOG 2015 FN Definition Study.
    Lavieri L; Koenig C; Bodmer N; Agyeman PKA; Scheinemann K; Ansari M; Roessler J; Ammann RA
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29253. PubMed ID: 34310027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing Time to Antibiotic Administration in Children with Possible Febrile Neutropenia through Quality Improvement Methodologies.
    Burns B; Hartenstein M; Lin A; Langley D; Burns E; Heilman J; Tanski M; Stork L; Ma OJ
    Pediatr Qual Saf; 2019; 4(6):e236. PubMed ID: 32010862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Febrile Neutropenia: Decreasing Time to Antibiotic Administration in a Community Hospital Emergency Department.
    Bruce SD
    Clin J Oncol Nurs; 2021 Feb; 25(1):23-26. PubMed ID: 33480869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: Is there room for improvement?
    Jansma B; Vakkalanka P; Talan DA; Negaard B; Faine BA
    J Oncol Pharm Pract; 2020 Sep; 26(6):1382-1389. PubMed ID: 31955667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration Time for the First Dose of Antimicrobials in Episodes of Fever and Neutropenia in Children With Cancer.
    De la Maza V; Simian D; Castro M; Torres JP; Lucero Y; Sepúlveda F; Mazquiaran S; Salazar C; Segovia L; Santolaya ME
    Pediatr Infect Dis J; 2015 Oct; 34(10):1069-73. PubMed ID: 26125587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.